Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Phase 3 Study of the Efficacy and Safety of ION582 in Children and Adults with Angelman Syndrome'.... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase 3, Open-Label, Multicenter, Extension Study of Acoramidis in Patients with Newly Diagnosed... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Healthy longevity with rapamycin (LONGER)'. The following are the other relevant details related t... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'FaR-RMS: An overarching study for children and adults with Frontline and Relapsed RhabdoMyoSarcoma... और पढ़ें
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07780032) titled 'Neuromodulation to Overcome Severe Restless Legs Syndrome' on Aug. 07. Brief Summary: This... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'Efficacy and safety of LUCONAC ® External Solution for the treatment of Onychomycosis in anopen la... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A multicenter, randomized, participant- and investigator - blinded, placebo-controlled, phase 2a s... और पढ़ें
Singapore, Aug. 22 -- The Health Sciences Authority received information related to the study titled 'A Phase III, 52-week, prospective, randomized, double-blind, placebo-controlled, parallel-group, m... और पढ़ें
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779785) titled 'VICA: A Virtual Care Assistant for Dementia Caregivers' on Aug. 12. Brief Summary: This pi... और पढ़ें
U.S., Aug. 22 -- ClinicalTrials.gov registry received information related to the study (NCT07779590) titled 'A Study to Learn About the Outcomes Between Study Medicines, Enzalutamide and Darolutamide ... और पढ़ें